| For: | Herath CB, Grace JA, Angus PW. Therapeutic potential of targeting the renin angiotensin system in portal hypertension. World J Gastrointest Pathophysiol 2013; 4(1): 1-11 [PMID: 23596549 DOI: 10.4291/wjgp.v4.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v4/i1/1.htm |
| Number | Citing Articles |
| 1 |
Manuel Morales-Ruiz, Juan Rodríguez-Vita, Jordi Ribera, Wladimiro Jiménez. PanVascular Medicine. 2015; doi: 10.1007/978-3-642-37078-6_144
|
| 2 |
Amal M. Mahfoz, Aya Y. Gawish. Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00935-5
|
| 3 |
Ibtesam A. Hilmi, Ali R. Abdullah. Anesthesia and Perioperative Care for Organ Transplantation. 2017; doi: 10.1007/978-1-4939-6377-5_34
|
| 4 |
Lakmie S Gunarathne, Harinda Rajapaksha, Nicholas Shackel, Peter W Angus, Chandana B Herath. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World Journal of Gastroenterology 2020; 26(40): 6111-6140 doi: 10.3748/wjg.v26.i40.6111
|
| 5 |
Tomer Adar, Yair Edden, Shimon Shteingart, Ami Ben Ya’acov, Mahmud Mahamid, Ellen Broide, Shimrit Shmorak, Ariella Bar-Gil Shitrit, Constantin Reinus, Eran Goldin. Portal hypertension is associated with modulation of regulatory T cells. European Journal of Inflammation 2016; 14(1) doi: 10.1177/1721727X15622960
|
| 6 |
Julliane V. Joviano‐Santos, Artur Santos‐Miranda, Humberto C. Joca, Jader S. Cruz, Anderson J. Ferreira. Diminazene aceturate (DIZE) has cellular and in vivo antiarrhythmic effects. Clinical and Experimental Pharmacology and Physiology 2020; 47(2) doi: 10.1111/1440-1681.13200
|
| 7 |
Lakmie S. Gunarathne, Indu G. Rajapaksha, Stephen Casey, Tawar Qaradakhi, Anthony Zulli, Harinda Rajapaksha, Jonel Trebicka, Peter W. Angus, Chandana B. Herath. Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats. Hepatology Communications 2022; 6(9) doi: 10.1002/hep4.1987
|
| 8 |
Chandana B. Herath, Kai Y. Mak, Peter W. Angus. The Protective Arm of the Renin Angiotensin System (RAS). 2015; doi: 10.1016/B978-0-12-801364-9.00034-1
|
| 9 |
Chang-qing Zhao, Yang Zhou, Jian Ping, Lie-ming Xu. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. Journal of Integrative Medicine 2014; 12(5) doi: 10.1016/S2095-4964(14)60039-X
|
| 10 |
Marco Di Pascoli, Vincenzo La Mura. Renin-angiotensin-aldosterone system in cirrhosis: There’s room to try!. Digestive and Liver Disease 2019; 51(2) doi: 10.1016/j.dld.2018.07.038
|
| 11 |
Indu Rajapaksha. Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches. Livers 2022; 2(4) doi: 10.3390/livers2040028
|
| 12 |
Manuel Morales-Ruiz, Juan Rodríguez-Vita, Jordi Ribera, Wladimiro Jiménez. PanVascular Medicine. 2014; doi: 10.1007/978-3-642-37393-0_144-1
|
| 13 |
Ahmed A. Shaaban, Mohamed E. Shaker, Khaled R. Zalata, Hassan A. El-kashef, Tarek M. Ibrahim. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3. Chemico-Biological Interactions 2014; 207 doi: 10.1016/j.cbi.2013.10.008
|
| 14 |
Adriano J. Pereira, Victor Jeger, René Fahrner, Siamak Djafarzadeh, Michael Lensch, Jukka Takala, Stephan M. Jakob. Interference of angiotensin II and enalapril with hepatic blood flow regulation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 307(6) doi: 10.1152/ajpgi.00150.2014
|
| 15 |
Nahla E El‐Ashmawy, Hoda A El‐Bahrawy, Maha M Shamloula, Amera O Ibrahim. Antifibrotic effect of AT‐1 blocker and statin in rats with hepatic fibrosis. Clinical and Experimental Pharmacology and Physiology 2015; 42(9) doi: 10.1111/1440-1681.12446
|